Melancholia: does this ancient concept have contemporary utility?
- 16 March 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in International Review of Psychiatry
- Vol. 32 (5-6), 466-470
- https://doi.org/10.1080/09540261.2019.1708708
Abstract
Many efforts have been made to develop coherent and clinically useful categories of depressive illness, especially to facilitate prediction of morbidity and guide treatment-response. They include proposals to resurrect the ancient concept of melancholia, as a form of severe depression with particular symptomatic and proposed psychobiological characteristics. However, modern research is inconsistent in supporting differences between melancholic and nonmelancholic depression. In our recent study of over 3200 patient-subjects with DSM-5 major depressive episodes with/without melancholic characteristics, and matched for illness severity, prevalence of melancholic features was 35.2% with remarkably few clinical and demographic differences between melancholic and nonmelancholic subjects. Also, our systematic review of trials comparing melancholic and nonmelancholic subjects found little difference in responses to antidepressant treatments. These findings indicate that the concept of melancholia may have limited value for clinical prediction and treatment-selection. Overlap of symptoms in melancholic and nonmelancholic depression, based on DSM criteria, may limit distinction of melancholia; alternative definitions can be sought, and psychomotor retardation is a particularly strong differentiating feature. For now, however, melancholia seems best considered a state-dependent depression-type strongly associated with greater symptomatic severity, rather than a distinct syndrome. Its DSM-5 current status as a depression-type specifier seems appropriate, and it may be a logical target for genetic and other biomedical studies.Keywords
This publication has 31 references indexed in Scilit:
- Issues for DSM-5: Whither Melancholia? The Case for Its Classification as a Distinct Mood DisorderAmerican Journal of Psychiatry, 2010
- Melancholia agitata and mixed depressionActa Psychiatrica Scandinavica, 2007
- Treatment response in melancholiaActa Psychiatrica Scandinavica, 2007
- Sleep and circadian rhythms in mood disordersActa Psychiatrica Scandinavica, 2007
- Pharmacological treatment for unipolar psychotic depressionThe British Journal of Psychiatry, 2006
- Antipsychotic drug use: McLean Hospital, 2002Human Psychopharmacology: Clinical and Experimental, 2005
- Classifying Depression: Should Paradigms Lost Be Regained?American Journal of Psychiatry, 2000
- Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depressionBiological Psychiatry, 1997
- Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressantsJournal of Affective Disorders, 1996
- Predicting the Response of Depressed Patients to Biological Treatment: the Dexamethasone Suppression Test Versus Clinical JudgementThe British Journal of Psychiatry, 1988